Twist Bioscience Corp Stock
Twist Bioscience Corp Stock
Twist Bioscience Corp took a tumble today and lost -€2.390 (-5.360%).
We see a rather positive sentiment for Twist Bioscience Corp with 13 Buy predictions and 1 Sell predictions.
On the other hand, the target price of 41 € is below the current price of 41.21 € for Twist Bioscience Corp, so the potential is actually -0.51%.
So far the community has only identified positive things for Twist Bioscience Corp stock. The most positive votes were given for criterium "Revenue growth".
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -5.360% | -0.218% | 15.921% | -4.029% | 47.971% | 95.077% | -67.032% |
| Rockwell Medical Inc. | -1.740% | 0.059% | -19.516% | -50.641% | 25.277% | -63.152% | -94.250% |
| Pacira Pharmaceuticals | -4.570% | 2.732% | 13.939% | -22.314% | -12.963% | -51.042% | -69.180% |
| Vericel Corp. | 0.000% | 6.623% | 3.205% | -37.476% | 1.899% | 15.661% | -24.678% |
Comments
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat